Atriopeptins, guanylate cyclase activators, and...

Details Atriopeptins, guanylate cyclase activators, and... Atriopeptins, guanylate cyclase activators, and...

A - Human Necessities

61

K

167/100

A61K 31/505 (2006.01) A61K 31/04 (2006.01) A61K 31/50 (2006.01) A61K 33/00 (2006.01) A61K 38/22 (2006.01)

Patent

CA 1319099

ABSTRACT OF THE DISCLOSURE The present invention relates to a method of treating cranial fluid volume dysfunctions such as edema, hydrocephalus, or glaucoma in an individual, comprising administering compounds which effect an increase in cyclic GMP at the site of the dysfunction or at the site of synthesis or removal of the accumulating fluid.

557141

Affiliated with

Also associated with

Rating

Atriopeptins, guanylate cyclase activators, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Atriopeptins, guanylate cyclase activators, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Atriopeptins, guanylate cyclase activators, and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1312581